IAC is looking to invest more in Dotdash Meredith, and is bullish on its big stake in casino company MGM Resorts.

image for news IAC Stock Is Rising. Barry Diller Is Returning to the Top With a Vision.

Cognizant's solution accelerator, powered by Elektrobit's Adaptive AUTOSAR solution, is designed to meet increasing customer demands by accelerating the development cycle for Software-Defined Vehicles TEANECK, N.J. , Feb. 12, 2025 /PRNewswire/ -- Cognizant (Nasdaq: CTSH) today announced a new collaboration with Elektrobit, an award-winning automotive software company, to integrate Elektrobit's Software Development Kit (SDK) for EB corbos AdaptiveCore into Cognizant's software-defined vehicle (SDV) solution accelerator.

image for news Cognizant and Elektrobit Collaborate to Accelerate Development of Software-Defined Vehicles

BENSALEM, Pa. , Feb. 12, 2025 /PRNewswire/ -- The Law Offices of Howard G.

image for news Revance Therapeutics, Inc. (RVNC) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa. , Feb. 12, 2025 /PRNewswire/ -- The Law Offices of Howard G.

image for news Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , Feb. 12, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to ModivCare, Inc. ("ModivCare" or the "Company") (NASDAQ: MODV) have opportunity to lead the securities fraud class action lawsuit.

image for news ModivCare, Inc. (MODV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , Feb. 12, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Crocs, Inc. ("Crocs" or the "Company") (NASDAQ: CROX). IF YOU SUFFERED A LOSS ON YOUR CROCS INVESTMENTS, CLICK HERE BEFORE MARCH 24, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

image for news Crocs, Inc. (CROX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

John Jarratt Reprises His Role as Mick Taylor, the Crocodile Dundee of Serial Killers! LOS ANGELES , Feb. 12, 2025 /PRNewswire/ -- Cineverse (NASDAQ: CNVS), a next-generation entertainment studio, and Bloody Disgusting, its horror division, have announced today the acquisition of Wolf Creek: Legacy , the third film of the incredibly popular slasher franchise.

image for news Cineverse Acquires North American Rights to Wolf Creek: Legacy, the Hotly Anticipated Third Installment of the Outback Slasher Franchise, From Architect Global

Investor Call and Webcast Scheduled for 4:30 P.M ET STONY BROOK, NY / ACCESS Newswire / February 12, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release its first quarter fiscal 2025 financial results after the market close on Thursday, February 13, 2025. The Company will host a conference call for shareholders and the investment community at 4:30 p.m.

image for news Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Transocean Ltd. (NYSE:RIG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transocean-ltd-lawsuit-submission-form?prid=129049&wire=1 or contact Joseph E.

image for news Levi & Korsinsky Notifies Transocean Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline - RIG

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Intellia Therapeutics, Inc. ("Intellia" or "the Company") (NASDAQ:NTLA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Intellia securities between July 30, 2024 and January 8, 2025, both dates inclusive (the "Class Period").

image for news NTLA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Intellia Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Crocs, Inc. (NASDAQ:CROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/crocs-inc-lawsuit-submission-form?prid=129050&wire=1 or contact Joseph E. Levi, Esq.

image for news Shareholders that lost money on Crocs, Inc.(CROX) should contact Levi & Korsinsky about pending Class Action - CROX

Cannabis REITs: Less Risky Choices In A Risky Sector — Neutral

IIPR  NLCP   Seeking Alpha — February 12, 2025

Cannabis stocks have underperformed due to unmet regulatory expectations and high leverage, making them risky investments despite low valuations, according to Julian Lin. NewLake Capital remains attractive due to its lack of debt and high yield, despite tenant issues similar to those faced by Innovative Industrial Properties.

image for news Cannabis REITs: Less Risky Choices In A Risky Sector

2 Gold Mining Stocks to Watch Amid Higher Prices — Positive

GOLD  NEM   Schaeffers Research — February 12, 2025

Fears surrounding higher interest rates reemerged after today's hotter-than-expected inflation data for January.

image for news 2 Gold Mining Stocks to Watch Amid Higher Prices

NiSource Q4 Earnings Surpass Estimates, 2025 EPS Guidance Raised — Positive

NI   Zacks Investment Research — February 12, 2025

NI's fourth-quarter earnings and revenues beat estimates. Interest expenses decline during the same period.

image for news NiSource Q4 Earnings Surpass Estimates, 2025 EPS Guidance Raised

Why CVS Health Stock Popped Today — Positive

CVS   The Motley Fool — February 12, 2025

Shares of CVS Health (CVS 13.66%) were soaring Wednesday after the diversified healthcare giant's fourth-quarter results topped estimates and management offered better-than-expected guidance for 2025.

image for news Why CVS Health Stock Popped Today

Westinghouse Air Brake Technologies Corporation (NYSE:WAB ) Q4 2024 - Earnings Conference Call February 12, 2025 8:30 AM ET Company Participants Kyra Yates - VP, IR Rafael Santana - President and CEO John Olin - CFO John Mastelers - SVP, Finance Conference Call Participants Robert Wertheimer - Melius Research Angel Castillo - Morgan Stanley Saree Boroditsky - Jefferies Ken Hoexter - Bank of America Daniel Imbro - Stephens Inc Jerry Revich - Goldman Sachs Bascome Majors - Susquehanna Ivan Yi - Wolfe Research Operator Good day, and welcome to the Wabtec's Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions].

image for news Westinghouse Air Brake Technologies Corporation (WAB) Q4 2024 Earnings Call Transcript

CVS Beats EPS Estimates, Losses Loom — Positive

CVS   The Motley Fool — February 12, 2025

CVS Health (CVS 13.34%), a leading integrated healthcare and pharmacy solutions provider, released its fourth-quarter 2024 earnings on February 12, 2025.

image for news CVS Beats EPS Estimates, Losses Loom

NEW YORK--(BUSINESS WIRE)--On February 12, 2025, the Board of Directors of The Arena Group Holdings, Inc. (NYSE American: AREN) terminated the employment of Sara Silverstein as CEO, effective immediately. As the company rapidly transforms, the Board believes a new entrepreneurial operational strategy is necessary to execute its exciting growth plan. The Board thanks Sara for her contributions as CEO which includes stabilizing the company and has named Paul Edmondson as interim CEO. Paul was for.

image for news The Arena Group Announces Termination of CEO, Sara Silverstein; Names Paul Edmondson as Interim CEO

Why Hims & Hers Terrifies Big Pharma — Neutral

HIMS   The Motley Fool — February 12, 2025

Hims & Hers (HIMS 1.82%) launched a Super Bowl ad this week, and everyone from pharmaceutical companies to pharmacists tried to block it. Travis Hoium explains why that's a great sign that the company's disruptive potential is real.

image for news Why Hims & Hers Terrifies Big Pharma

Corning Announces Quarterly Dividend — Neutral

GLW   Business Wire — February 12, 2025

CORNING, N.Y.--(BUSINESS WIRE)--Corning Incorporated's (NYSE: GLW) Board of Directors today declared a quarterly dividend of $0.28 per share. The dividend will be payable on March 28, 2025, to shareholders of record on February 28, 2025. Caution Concerning Forward-Looking Statements The statements contained in this release and related comments by management that are not historical facts or information and contain words such as “will,” “believe,” “anticipate,” “expect,” “intend,” “plan,” “seek,”.

image for news Corning Announces Quarterly Dividend